Finance

Lists
Why is EPRX down 10,51%?
Dive Deeper
EPRX:TSE
Eupraxia Pharmaceuticals Inc
9,45 CAD
-10,51%
(-1,11) 1D
17-ноя., 16:00:00 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for EPRX...
Open
10,36 CAD
High
10,49 CAD
Low
9,36 CAD
Mkt. cap
635,44 млн
Avg. vol.
90,54 миң
Volume
183,66 миң
52-wk high
13,08 CAD
52-wk low
7,85 CAD
EPS
-1,34 CAD
Beta
1,25
Shares outstanding
67,27 млн
No. of employees
49
Open
10,36 CAD
High
10,49 CAD
Low
9,36 CAD
Mkt. cap
635,44 млн
Avg. vol.
90,54 миң
Volume
183,66 миң
52-wk high
13,08 CAD
52-wk low
7,85 CAD
EPS
-1,34 CAD
Beta
1,25
Shares outstanding
67,27 млн
No. of employees
49
News stories
From web sources and news partners
About Eupraxia Pharmaceuticals Inc
CEO-
Employees49
Founded2011
HeadquartersВиктория, Бритиш Колумбия, Канада
SectorHealth Care
Industry-
Last report
2026-ж., 10-ноя.
Fiscal period
Q3 2026
-0,33 CAD / -
Revenue / Est. (CAD)
- / 0,00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,87 млн
11,17 млн
12,81 млн
10,82 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,30 млн
4,78 млн
5,30 млн
5,34 млн
Operating expense
16,16 млн
15,96 млн
18,10 млн
16,16 млн
Total operating expenses
16,16 млн
15,96 млн
18,10 млн
16,16 млн
Operating income
-16,16 млн
-15,96 млн
-18,10 млн
-16,16 млн
Other non operating income
-
-
-
-
EBT including unusual items
-16,71 млн
-12,64 млн
-14,46 млн
-15,26 млн
EBT excluding unusual items
-16,71 млн
-12,64 млн
-14,46 млн
-15,25 млн
Income tax expense
11,34 миң
13,90 миң
30,38 миң
-7,17 миң
Effective tax rate
-0,07%
-0,11%
-0,21%
0,05%
Other operating expenses
-
-
-
-
Net income
-16,71 млн
-12,65 млн
-14,49 млн
-15,24 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
666,92 миң
1,07 млн
1,39 млн
1,22 млн
Interest expense
-
-
-
-
Net interest expenses
666,92 миң
1,07 млн
1,39 млн
1,22 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-16,11 млн
-15,90 млн
-18,02 млн
-15,90 млн
Gain or loss from assets sale
1,49 миң
-
2,70 миң
1,41 миң
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору